Urogen Pharma (NASDAQ:URGN) Releases Quarterly Earnings Results, Beats Estimates By $0.01 EPS
Urogen Pharma (NASDAQ:URGN - Get Free Report) released its quarterly earnings data on Wednesday. The company reported ($0.47) earnings per share for the quarter, topping analysts' consensus estimates of ($0.48) by $0.01. The company had revenue of $50.96 million for the quarter, compared to analyst...